Terrie Curran
Director · 3 filings · Latest: Aug 27, 2026
Arcutis Biotherapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ARQT | Terrie Curran | Director | Aug 27, 2026 | Sale | $25.03 | 38,200 | $956.1K | 23,526 | |
ARQT | Terrie Curran | Director | Aug 27, 2026 | Option Exercise | $8.30 | 38,200 | $317.2K | 50,578 | |
ARQT | Terrie Curran | — | Aug 27, 2026 | Proposed Sale | $25.03 | 38,200 | $956.1K | — | |
ARQT | Terrie Curran | Director | Aug 20, 2026 | Sale | $26.04 | 1,072 | $27.9K | 23,526 | |
ARQT | Terrie Curran | Director | Aug 20, 2026 | Option Exercise | $7.51 | 1,072 | $8.1K | 24,598 | |
ARQT | Terrie Curran | — | Aug 20, 2026 | Proposed Sale | $26.04 | 1,072 | $27.9K | — | |
ARQT | Curran Terrie | — | Nov 11, 2024 | Proposed Sale | $10.85 | 8,687 | $94.2K | — |